MyAverix Finance
F · Healthcare
Diamyd Medical AB (publ) (DMN)
Biotechnology
Diamyd Medical AB (publ) (DMN) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-28, reported market cap is $193.32M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for DMN
Diamyd Medical AB (publ) (DMN) — FAQ
What is Diamyd Medical AB (publ)'s market cap?
Diamyd Medical AB (publ) (DMN) has a reported market cap of $193.32M (data as of 2026-03-28).
What is DMN's P/E ratio?
The price-to-earnings (P/E) ratio for Diamyd Medical AB (publ) (DMN) is 18.00 (data as of 2026-03-28).
Does Diamyd Medical AB (publ) pay a dividend?
Dividend yield is not available in the current snapshot for Diamyd Medical AB (publ) (DMN). Check the MyAverix Finance app for the latest dividend data.
What sector is Diamyd Medical AB (publ) in?
Diamyd Medical AB (publ) (DMN) is classified in the Healthcare sector (Biotechnology industry).
What exchange is DMN listed on?
DMN is listed on F.
What is Diamyd Medical AB (publ)'s net margin?
Diamyd Medical AB (publ) (DMN) reports a net margin of 0.0% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.